PMID: 25797246Mar 24, 2015Paper

Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer

Oncotarget
Ping ChenLijun Jia

Abstract

Liver cancer is the second-most frequent cause of cancer death in the world and is highly treatment resistant. We reported previously that inhibition of neddylation pathway with specific NAE inhibitor MLN4924, suppressed the malignant phenotypes of liver cancer. However, during the process, MLN4924 induces pro-survival autophagy as a mechanism of drug resistance. Here, we report that blockage of autophagy with clinically-available autophagy inhibitors (e.g. chloroquine) significantly enhanced the efficacy of MLN4924 on liver cancer cells by triggering apoptosis. Mechanistically, chloroquine enhanced MLN4924-induced up-regulation of pro-apoptotic proteins (e.g. NOXA) and down-regulation of anti-apoptotic proteins. Importantly, the down-regulation of NOXA expression via siRNA silencing substantially attenuated apoptosis of liver cancer cells. Further mechanistic studies revealed that blockage of autophagy augmented MLN4924-induced DNA damage and reactive oxygen species (ROS) generation. The elimination of DNA damage or blockage of ROS production significantly reduced the expression of NOXA, and thereby attenuated apoptosis and reduced growth inhibition of liver cancer cells. Moreover, blockage of autophagy enhanced the efficacy o...Continue Reading

References

Oct 1, 2005·Nature Reviews. Cancer·Robert M Hoffman
Jan 12, 2007·Apoptosis : an International Journal on Programmed Cell Death·Jane L ArmstrongPenny E Lovat
Oct 16, 2007·Cancer Cell·Thierry Soussi, Klas G Wiman
Apr 11, 2009·Nature·Teresa A SoucySteven P Langston
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa A SoucyMark Rolfe
Jul 31, 2009·Oncogene·C PlonerA Villunger
Jan 16, 2010·Expert Opinion on Investigational Drugs·Piotr Jan Wysocki
Feb 11, 2010·Cell·Noboru MizushimaBeth Levine
Jan 12, 2011·Expert Opinion on Therapeutic Targets·Meng WangRonan T Swords
Feb 15, 2011·Cancer Cell·Ian R WatsonMichael Ohh
Mar 17, 2011·Gastroenterology·Augusto Villanueva, Josep M Llovet
Jun 3, 2011·Journal of Neuro-oncology·Sachiko Ohshima-HosoyamaCharles Keller
Jul 23, 2011·Genes & Cancer·Teresa A SoucyJames E Brownell
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Jul 18, 2012·Expert Opinion on Investigational Drugs·Steffan T NawrockiJennifer S Carew
Sep 12, 2012·Autophagy·Daniel J KlionskyBrian Zuckerbraun
Dec 22, 2012·Chemotherapy·A F BritoM F Botelho
May 2, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steffan T NawrockiJennifer S Carew
May 30, 2013·Trends in Molecular Medicine·Hannelore MaesPatrizia Agostinis
Oct 26, 2013·Liver Cancer·Agrin MoeiniAugusto Villanueva
Oct 26, 2013·Liver Cancer·Shibo LinPeter Schemmer
Jan 15, 2014·Antioxidants & Redox Signaling·Yongchao ZhaoYi Sun

❮ Previous
Next ❯

Citations

Dec 9, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yubin LiDianwen Ju
Aug 22, 2015·Journal of Chemotherapy·Maryam OladghaffariAli Shabestani Monfared
Aug 24, 2016·Cell Death Discovery·L-X ZhongH Li
Jan 7, 2016·Oncotarget·Marta Anna KowalikLaura Falasca
Aug 10, 2017·Applied Microbiology and Biotechnology·Chit TamTzi Bun Ng
Oct 8, 2020·The FEBS Journal·Tao Zou, Jiyan Zhang
Dec 28, 2017·Journal of Cellular Biochemistry·Wei-Chih LienChia-Yih Wang
Mar 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ping ChenLijun Jia
Jan 13, 2021·Pflügers Archiv : European journal of physiology·Qin GuoChong Zhang
Nov 13, 2020·Pharmacological Reviews·Samir H Barghout, Aaron D Schimmer
Feb 13, 2021·Trends in Cell Biology·Guang LuHan-Ming Shen
Jan 21, 2021·Biotechnology and Applied Biochemistry·Xin HeXiaobin Wang
Mar 19, 2021·Cell & Bioscience·Qiyin ZhouYi Sun
Jul 12, 2018·Journal of Agricultural and Food Chemistry·Tsui-Ling ChangPei-Jane Tsai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis